MoneyWorks4Me

Neuland Laboratories - Quaterly Results

07 Nov 2023 Evaluate
The sales surged to Rs. 4177.49 millions, up 42.23% for the September 2023 quarter as against Rs. 2937.06 millions during the corresponding quarter previous year.The company almost doubled its revenue to Rs. 890.65 millions  from Rs. 383.34 millions in the quarter ended September 2023.Operating profit surged to 1403.46 millions from the corresponding previous quarter of 694.09 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 4177.49 2937.06 42.23 7807.43 5148.76 51.64 11911.98 9510.77 25.25
Other Income 30.48 2.39 1175.31 50.87 7.51 577.36 97.48 20.77 369.33
PBIDT 1403.46 694.09 102.20 2396.50 983.99 143.55 2810.56 1442.71 94.81
Interest 44.33 31.75 39.62 66.47 60.33 10.18 130.67 134.94 -3.16
PBDT 1359.13 662.34 105.20 2330.03 923.66 152.26 2679.89 1307.77 104.92
Depreciation 145.08 131.72 10.14 280.94 259.70 8.18 527.76 490.36 7.63
PBT 1214.05 530.62 128.80 2049.09 663.96 208.62 2152.13 817.41 163.29
TAX 323.40 147.28 119.58 536.20 182.21 194.28 520.94 182.06 186.14
Deferred Tax 9.03 3.96 128.03 12.36 -2.11 -685.78 17.04 -22.16 -176.90
PAT 890.65 383.34 132.34 1512.89 481.75 214.04 1631.19 635.35 156.74
Equity 129.01 129.01 0.00 129.01 129.01 0.00 129.01 129.01 0.00
PBIDTM(%) 33.60 23.63 42.16 30.70 19.11 60.61 23.59 15.17 55.54
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..